Paul A. Seligman M.D.

Professor of Medicine

Go To Full Curriculum Vitae

Medical School:
State University of New York at Buffalo School of Medicine, Buffalo, New York
Postgraduate training:
1972-1973 Intern in Medicine, State University of New York at Buffalo Affiliated Hospitals, Buffalo, NY
1973-1975 Resident in Medicine, State University of New York at Buffalo Affiliated Hospitals, Buffalo, NY
1975-1978 Fellow in Hematology/Oncology, Washington University School of Medicine, St. Louis, MO
When arrived at UCD:
1978
Past and current professional positions:
1978-1984 Assistant Professor of Medicine, University of Colorado School of Medicine, Denver, CO
1983-Present Director/Preceptor -Specific elective course in Hospice Medicine For Senior
Medical Students
1983-Present Course Director Medicine 6000 -Hematology section of Sophomore course
Pathophysiology of Disease
1984-1991 Associate Professor of Medicine, University of Colorado School of Medicine, Denver, CO
1984-Present Medical Director - Hospice of St. John
1988- Present Course Director Medicine 7000 - Clerkship in Internal Medicine For Junior
Medicine Students
1988-Present Director - Medicine elective courses For Senior Medical Students
1991-Present Professor of Medicine, University of Colorado School of Medicine, Denver, CO
1994-2001 Coordinator of Medical School Curriculum - Chair of Curriculum Committee
and Curriculum Review Committee University of Colorado School of Medicine
2001-Present Coordinator of Fourth Year Curriculum, University of Colorado School of
Medicine, Denver, CO
Memberships and other information:
American Society of Hematology
American Society for Clinical Investigation
Academy of Hospice Physicians (founding member)
Clerkship Directors of Internal Medicine
Board Certification:
Internal Medicine - 1975
Hematology - 1980
Medical Oncology - 1983
Awards received:
1972 Alpha Omega Alpha
Major Scientific Interest:
Cell surface receptors and cellular proliferation
Major Clinical Interest:
Diagnosis and treatment of nutritional deficiency, breast cancer, nutritional aspects of cancer treatment and prevention
Representative Publications:
  1. Seligman, P.A., and Allen, R.H. Characterization of the receptor for transcobalamin II isolated from human placenta. J Biol Chem 253:1766-1772, 1978.
  2. Seligman, P.A., Schleicher, R.B., and Allen, R.H. Isolation and characterization of the transferrin receptor from human placenta. J Biol Chem 254:9943-9946, 1979.
  3. Seligman, P.A., Allen, R.H., Kirchanski, S.J., and Natale, P.J. Automated analysis of reticulocytes using fluorescent staining with both acridine orange and an immunofluorescence technique. Am J Hematol 14:57-66, 1983.
  4. Miller, Y.E., Jones, C., Scoggin, C.H., Morese, H., and Seligman, P.A. Chromosome 3q (22-ter) encodes the human transferrin receptor. Am J Hum Genet 35:573-583, 1983.
  5. Vostrejs, M., Moran, P., and Seligman, P.A. Transferrin synthesis by small cell lung cancer cells acts as an autocrine regulator of cellular proliferation. J Clin Invest 82:331-339, 1988.
  6. Seligman, P.A., Schleicher, R.B., Siriwardana, G., Domenico, J., and Gelfand, E.W. Effects of agents that inhibit cellular iron incorporation on bladder cancer cell proliferation. Blood 82:1608-1617, 1993.
  7. Allen, J., Backstrom, K., Cooper, J., Detwiler, T.C., Essex, D.W., Fritz, R., Means, R.T., Meier, P.B., Pearlman, S., Roitman-Johnson, B., and Seligman, P.A. Measurement of soluble transferrin receptor in serum of healthy adults. Clin Chem 44:35-39, 1998.
  8. Seligman, P.A. Hemochromatosis. Primary Care Case Rev 4 (1):40-46, 2001.
  9. Nissenson A.R., Berns J.S., Sakiewicz P., Ghaddar S., Moore G.M., Schleicher R.B., and Seligman P.A. Clinical evaluation of heme iron polypeptide: Sustaining a response to rHuEPO in hemodialysis patients. Am J Kidney Dis 42:325-330, 2003.
univeristy of colorado health sciences center department of medicine at u c h s c school of medicine at u c h s c division of infectious diseases home